XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
shares
Supplemental disclosures of non-cash investing and financing activities        
Fair value of shares issued     $ 17,598  
Common stock issued through the dividend reinvestment plan (in shares) | shares     2,721 2,777
Common stock issued through the dividend reinvestment plan     $ 558 $ 521
Number of shares withheld to satisfy employees' tax withholding and other liabilities (in shares) | shares     73,652 93,181
Shares withheld to satisfy employees' tax withholding and other liabilities     $ 16,518 $ 16,643
Stock issued during period, value, share-based compensation, forfeited     528 732
Payments to acquire other real estate     643,975 278,363
Dividends payable, common stock and DownREIT unit $ 250,082   250,082  
Gain (loss) on cash flow hedges 36 $ 470 (5,824) 12,308
Cash flow hedge gains reclassified to earnings $ (1,423) (274) (2,266) (197)
Dividends declared but not paid   $ 243,029   243,029
Increase in derivative assets       $ 12,308
Deferred Compensation, Share-based Payments | Non employee director        
Supplemental disclosures of non-cash investing and financing activities        
Equity instruments granted (in shares) | shares       12,290
Fair value of shares issued       $ 1,972
DownREIT Partnership        
Supplemental disclosures of non-cash investing and financing activities        
Payments to acquire apartment homes     $ 415,579  
Restricted Stock and Common Stock Converted from Performance Shares        
Supplemental disclosures of non-cash investing and financing activities        
Equity instruments granted (in shares) | shares     182,815 250,806
Performance Shares        
Supplemental disclosures of non-cash investing and financing activities        
Equity instruments granted (in shares) | shares     78,937  
Converted to restricted stock (in shares) | shares     103,332 146,725
Restricted stock        
Supplemental disclosures of non-cash investing and financing activities        
Equity instruments granted (in shares) | shares     79,483 104,081
Fair value of shares issued       $ 18,020
Stock issued during period, shares, share-based compensation, forfeited (in shares) | shares     2,681 4,021